Human milk lipids provide the infant with energy and essential vitamins, polyunsaturated fatty acids, and bioactive components. Adding complex lipids and milk fat globule membranes to vegetable oil-based infant formula has the potential to enhance infant development and reduce infections. Cholesterol provision with breastfeeding modulates infant sterol metabolism and may induce long-term benefits. Some 98-99% of milk lipids are comprised by triacylglycerols, whose properties depend on incorporated fatty acids. Attention has been devoted to the roles of the long-chain polyunsaturated fatty acids docosahexaenoic (DHA) and arachidonic (ARA) acids. Recent studies on gene-diet interaction (Mendelian randomization) show that breastfeeding providing DHA and ARA improves cognitive development and reduces asthma risk at school age particularly in those children with a genetically determined lower activity of DHA and ARA synthesis. It appears prudent to follow the biological model of human milk in the design of infant formula as far as feasible, unless conclusive evidence for the suitability and safety of other choices is available. The recent European Union legislative stipulation of a high formula DHA content without required ARA deviates from this concept, and such a novel formula composition has not been adequately evaluated. Great future opportunities arise with significant methodological progress for example in lipidomic analyses and their bioinformatic evaluation, which should enhance understanding of the biology of human milk lipids. Such knowledge might lead to improved dietary advice to lactating mothers as well as to further opportunities to enhance infant formula composition.

1.
Koletzko B, Agostoni C, Bergmann R, Ritzenthaler K, Shamir R: Physiological aspects of human milk lipids and implications for infant feeding: a workshop report. Acta Paediatr 2011;100:1405-1415.
2.
Delplanque B, Gibson R, Koletzko B, Lapillonne A, Strandvik B: Lipid quality in infant nutrition: current knowledge and future opportunities. J Pediatr Gastroenterol Nutr 2015;61:8-17.
3.
Krohn K, Demmelmair H, Koletzko B: Macronutrient requirements for growth: fats and fatty acids; in Duggan C, Watkins JB, Koletzko B, Walker WA (eds): Nutrition in Pediatrics, ed 5. Raleigh, People's Medical Publishing House, 2016, in press.
4.
Grote V, Verduci E, Scaglioni S, Vecchi F, Contarini G, Giovannini M, et al: Breast milk composition and infant nutrient intakes during the first 12 months of life. Eur J Clin Nutr 2016;70:250-256.
5.
Michaelsen KF, Skafte L, Badsberg JH, Jorgensen M: Variation in macronutrients in human bank milk: influencing factors and implications for human milk banking. J Pediatr Gastroenterol Nutr 1990;11:229-239.
6.
Koletzko B, Rodriguez-Palmero M, Demmelmair H, Fidler N, Jensen R, Sauerwald T: Physiological aspects of human milk lipids. Early Hum Dev 2001;65(suppl):S3-S18.
7.
Michaelsen KF, Larsen PS, Thomsen BL, Samuelson G: The Copenhagen Cohort Study on Infant Nutrition and Growth: breast-milk intake, human milk macronutrient content, and influencing factors. Am J Clin Nutr 1994;59:600-611.
8.
Keating EM, Curtis BA, Slusher TM: Maternal milk volume and breast milk expression: implications for diet and nutrition in infants; in Zibadi S, Watson RR, Preedy VR (eds): Handbook of Dietary and Nutritional Aspects of Human Breast Milk. Wageningen, Wageningen Academic Publishers, 2013, pp 193-213.
9.
Hernell O, Timby N, Domellof M, Lonnerdal B: Clinical benefits of milk fat globule membranes for infants and children. J Pediatr 2016;173(suppl):S60-S65.
10.
Giuffrida F, Cruz-Hernandez C, Fluck B, Tavazzi I, Thakkar SK, Destaillats F, et al: Quantification of phospholipids classes in human milk. Lipids 2013;48:1051-1058.
11.
Tanaka K, Hosozawa M, Kudo N, Yoshikawa N, Hisata K, Shoji H, et al: The pilot study: sphingomyelin-fortified milk has a positive association with the neurobehavioural development of very low birth weight infants during infancy, randomized control trial. Brain Dev 2013;35:45-52.
12.
Gurnida DA, Rowan AM, Idjradinata P, Muchtadi D, Sekarwana N: Association of complex lipids containing gangliosides with cognitive development of 6-month-old infants. Early Hum Dev 2012;88:595-601.
13.
Zavaleta N, Kvistgaard AS, Graverholt G, Respicio G, Guija H, Valencia N, et al: Efficacy of an MFGM-enriched complementary food in diarrhea, anemia, and micronutrient status in infants. J Pediatr Gastroenterol Nutr 2011;53:561-568.
14.
Veereman-Wauters G, Staelens S, Rombaut R, Dewettinck K, Deboutte D, Brummer RJ, et al: Milk fat globule membrane (INPULSE) enriched formula milk decreases febrile episodes and may improve behavioral regulation in young children. Nutrition 2012;28:749-752.
15.
Timby N, Hernell O, Vaarala O, Melin M, Lonnerdal B, Domellof M: Infections in infants fed formula supplemented with bovine milk fat globule membranes. J Pediatr Gastroenterol Nutr 2015;60:384-389.
16.
Timby N, Domellof E, Hernell O, Lonnerdal B, Domellof M: Neurodevelopment, nutrition, and growth until 12 mo of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial. Am J Clin Nutr 2014;99:860-868.
17.
Mutemberezi V, Guillemot-Legris O, Muccioli GG: Oxysterols: From cholesterol metabolites to key mediators. Prog Lipid Res 2016;64:152-169.
18.
Kinney HC, Karthigasan J, Borenshteyn NI, Flax JD, Kirschner DA: Myelination in the developing human brain: biochemical correlates. Neurochem Res 1994;19:983-996.
19.
Cartocci V, Servadio M, Trezza V, Pallottini V: Can cholesterol metabolism modulation affect brain function and behavior? J Cell Physiol 2016;232:281-286.
20.
Shamir R, Nganga A, Berkowitz D, Diamond E, Lischinsky S, Lombardo D, et al: Serum levels of bile salt-stimulated lipase and breast feeding. J Pediatr Endocrinol Metab 2003;16:1289-1294.
21.
Wong WW, Hachey DL, Insull W, Opekun AR, Klein PD: Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants. J Lipid Res 1993;34:1403-1411.
22.
Devlin AM, Innis SM, Shukin R, Rioux MF: Early diet influences hepatic hydroxymethyl glutaryl coenzyme A reductase and 7alpha-hydroxylase mRNA but not low-density lipoprotein receptor mRNA during development. Metabolism 1998;47:20-26.
23.
Cruz ML, Wong WW, Mimouni F, Hachey DL, Setchell KD, Klein PD, et al: Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994;35:135-140.
24.
Owen CG, Whincup PH, Odoki K, Gilg JA, Cook DG: Infant feeding and blood cholesterol: a study in adolescents and a systematic review. Pediatrics 2002;110:597-608.
25.
Owen CG, Whincup PH, Kaye SJ, Martin RM, Davey Smith G, Cook DG, et al: Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am J Clin Nutr 2008;88:305-314.
26.
Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, Trikalinos T, Lau J: Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) 2007;(153):1-186 .
27.
ESPGHAN Committee on Nutrition, Agostoni C, Braegger C, Decsi T, Kolacek S, Koletzko B, et al: Breast-feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2009;49:112-125.
28.
Carnielli VP, Luijendijk IH, Van Goudoever JB, Sulkers EJ, Boerlage AA, Degenhart HJ, et al: Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance. J Pediatr Gastroenterol Nutr 1996;23:553-560.
29.
Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P: Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006;45:203-236.
30.
Demmelmair H, Baumheuer M, Koletzko B, Dokoupil K, Kratl G: Metabolism of U13C-labeled linoleic acid in lactating women. J Lipid Res 1998;39:1389-1396.
31.
Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM: Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr 2007;85:1457-1464.
32.
Del Prado M, Villalpando S, Elizondo A, Rodriguez M, Demmelmair H, Koletzko B: Contribution of dietary and newly formed arachidonic acid to human milk lipids in women eating a low-fat diet. Am J Clin Nutr 2001;74:242-247.
33.
Fidler N, Sauerwald T, Pohl A, Demmelmair H, Koletzko B: Docosahexaenoic acid transfer into human milk after dietary supplementation: a randomized clinical trial. J Lipid Res 2000;41:1376-1383.
34.
Koletzko B, Boey CCM, Campoy C, Carlson SE, Chang N, Guillermo-Tuazon MA, et al: Current information and Asian perspectives on long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy. Systematic review and practice recommendations from an Early Nutrition Academy workshop. Ann Nutr Metab 2014;65:49-80.
35.
Novak EM, Dyer RA, Innis SM: High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res 2008;1237:136-145.
36.
EFSA Panel on Dietetic Products, Nutrition and Allergies: DHA and ARA and visual development - scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and visual development pursuant to Article14 of Regulation (EC) No 1924/2006[1]. EFSA J 2009;941:1-14.
37.
Qawasmi A, Landeros-Weisenberger A, Bloch MH: Meta-analysis of LCPUFA supplementation of infant formula and visual acuity. Pediatrics 2013;131:e262-e272.
38.
Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH: Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics 2012;129:1141-1149.
39.
Glaser C, Heinrich J, Koletzko B: Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 2010;59:993-999.
40.
Glaser C, Lattka E, Rzehak P, Steer C, Koletzko B: Genetic variation in polyunsaturated fatty acid metabolism and its potential relevance for human development and health. Matern Child Nutr 2011;7(suppl 2):27-40.
41.
Lattka E, Illig T, Koletzko B, Heinrich J: Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 2010;21:64-69.
42.
Lattka E, Rzehak P, Szabo E, Jakobik V, Weck M, Weyermann M, et al: Genetic variants in the FADS gene cluster are associated with arachidonic acid concentrations of human breast milk at 1.5 and 6 mo postpartum and influence the course of milk dodecanoic, tetracosenoic, and trans-9-octadecenoic acid concentrations over the duration of lactation. Am J Clin Nutr 2011;93:382-391.
43.
Steer CD, Davey Smith G, Emmett PM, Hibbeln JR, Golding J: FADS2 polymorphisms modify the effect of breastfeeding on child IQ. PLoS One 2010;5:e11570.
44.
Morales E, Bustamante M, Gonzalez JR, Guxens M, Torrent M, Mendez M, et al: Genetic variants of the FADS gene cluster and ELOVL gene family, colostrums LC-PUFA levels, breastfeeding, and child cognition. PLoS One 2011;6:e17181.
45.
Jensen CL, Maude M, Anderson RE, Heird WC: Effect of docosahexaenoic acid supplementation of lactating women on the fatty acid composition of breast milk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr 2000;71(1 suppl):292S-9S.
46.
Standl M, Sausenthaler S, Lattka E, Koletzko S, Bauer CP, Wichmann HE, et al: FADS gene cluster modulates the effect of breastfeeding on asthma. Results from the GINIplus and LISAplus studies. Allergy 2012;67:83-90.
47.
European Commission: Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding. Official Journal of the European Union 2016:L25/1.
48.
EFSA Panel on Dietetic Products, Nutrition and Allergies: Scientific opinion on nutrient requirements and dietary intakes of infants and young children in the European Union. EFSA J 2013;11:3408.
49.
EFSA Panel on Dietetic Products, Nutrition and Allergies: Scientific opinion on the essential composition of infant and follow-on formulae. EFSA J 2014;12:106.
50.
Koletzko B, Carlson SE, van Goudoever JB: Should infant formula provide both omega-3 DHA and omega-6 arachidonic acid? Ann Nutr Metab 2015;66:137-138.
51.
Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA: Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994;60:189-194.
52.
Martinez M: Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-S138.
53.
Larque E, Ruiz-Palacios M, Koletzko B: Placental regulation of fetal nutrient supply. Curr Opin Clin Nutr Metab Care 2013;16:292-297.
54.
Steer CD, Lattka E, Koletzko B, Golding J, Hibbeln JR: Maternal fatty acids in pregnancy, FADS polymorphisms, and child intelligence quotient at 8 y of age. Am J Clin Nutr 2013;98:1575-1582.
55.
Kohlboeck G, Glaser C, Tiesler C, Demmelmair H, Standl M, Romanos M, et al: Effect of fatty acid status in cord blood serum on children's behavioral difficulties at 10 y of age: results from the LISAplus Study. Am J Clin Nutr 2011;94:1592-1599.
56.
Demmelmair H, Koletzko B: Importance of fatty acids in the perinatal period. World Rev Nutr Diet 2015;112:31-47.
57.
Koletzko B, Schmidt E, Bremer HJ, Haug M, Harzer G: Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants. Eur J Pediatr 1989;148:669-675.
58.
Carlson SE, Cooke RJ, Rhodes PG, Peeples JM, Werkman SH: Effect of vegetable and marine oils in preterm infant formulas on blood arachidonic and docosahexaenoic acids. J Pediatr 1992;120:S159-S167.
59.
Makrides M, Neumann MA, Simmer K, Gibson RA: Erythrocyte fatty acids of term infants fed either breast milk, standard formula, or formula supplemented with long-chain polyunsaturates. Lipids 1995;30:941-948.
60.
Codex Alimentarius Commission: Standard for infant formula and formulas for special medical purposes intended for infants. Codex Stan 72 - 1981. Rome, Codex Alimentarius Commission 2007, pp 1-21.
61.
Koletzko B, Sauerwald T, Demmelmair H, Herzog M, von Schenck U, Bohles H, et al: Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial. J Inherit Metab Dis 2007;30:326-332.
62.
Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA: Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993;90:1073-1077.
63.
Carlson SE, Cooke RJ, Werkman SH, Tolley EA: First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992;27:901-907.
64.
Colombo J, Carlson SE, Cheatham CL, Shaddy DJ, Kerling EH, Thodosoff JM, et al: Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr 2013;98:403-412.
65.
Committee on the Evaluation of the Addition of Ingredients New to Infant Formula, Food and Nutrition Board, Institute of Medicine: Infant Formula. Evaluating the Safety of New Ingredients. Washington, The National Academy Press, 2001.
66.
ESPGHAN Committee on Nutrition, Aggett PJ, Agostini C, Goulet O, Hernell O, Koletzko B, et al: The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2001;32:256-258.
67.
Koletzko B, Ashwell M, Beck B, Bronner A, Mathioudakis B: Characterisation of infant food modifications in the European Union. Ann Nutr Metab 2002;46:231-242.
68.
Koletzko B, Szajewska H, Ashwell M, Shamir R, Aggett P, Baerlocher K, et al: Documentation of functional and clinical effects of infant nutrition: setting the scene for COMMENT. Ann Nutr Metab 2012;60:222-232.
69.
Koletzko B, Shamir R, Ashwell M: Quality and safety aspects of infant nutrition. Ann Nutr Metab 2012;60:179-184.
70.
European Commission, Scientific Committee on Food; Koletzko B, Saris WH, Flynn A, Palou A, Wal JM, et al: Report of the Scientific Committee on Food on the Revision of Essential Requirements of Infant Formulae and Follow-on Formulae. Brussels, European Commission, 2003.
71.
Uhl O, Hellmuth C, Demmelmair H, Zhou SJ, Makrides M, Prosser C, et al: Dietary effects on plasma glycerophospholipids. J Pediatr Gastroenterol Nutr 2015;61:367-372.
72.
Uhl O, Glaser C, Demmelmair H, Koletzko B: Reversed phase LC/MS/MS method for targeted quantification of glycerophospholipid molecular species in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:3556-3564.
73.
Hellmuth C, Uhl O, Segura-Moreno M, Demmelmair H, Koletzko B: Determination of acylglycerols from biological samples with chromatography-based methods. J Sep Sci 2011;34:3470-3483.
74.
Hellmuth C, Weber M, Koletzko B, Peissner W: Nonesterified fatty acid determination for functional lipidomics: comprehensive ultrahigh performance liquid chromatography-tandem mass spectrometry quantitation, qualification, and parameter prediction. Anal Chem 2012;84:1483-1490.
75.
Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Bluher M, Koletzko B: Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS One 2013;8:e74927.
76.
Rauschert S, Uhl O, Koletzko B, Kirchberg F, Mori TA, Huang RC, et al: Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults. J Clin Endocrinol Metab 2016;101:871-879.
77.
Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, et al: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr 2015;54:173-181.
78.
Rzehak P, Hellmuth C, Uhl O, Kirchberg FF, Peissner W, Harder U, et al: Rapid growth and childhood obesity are strongly associated with LysoPC(14:0). Ann Nutr Metab 2014;64:294-303.
79.
Khan S, Hepworth AR, Prime DK, Lai CT, Trengove NJ, Hartmann PE: Variation in fat, lactose, and protein composition in breast milk over 24 hours: associations with infant feeding patterns. J Hum Lact 2013;29:81-89.
You do not currently have access to this content.